{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:05:53Z","timestamp":1792188353398,"version":"4.4.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.eimc.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T08:38:09Z","timestamp":1277973489000},"page":"726-736","source":"Crossref","is-referenced-by-count":16,"title":["Lectura interpretada del antibiograma de bacilos gramnegativos no fermentadores"],"prefix":"10.1016","volume":"28","author":[{"given":"Jordi","family":"Vila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropiate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2007.01681.x","article-title":"Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millenium","volume":"13","author":"Mesaros","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dki303","article-title":"Simple method to determine \u03b2-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test","volume":"56","author":"Vedel","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1099\/00222615-18-2-261","article-title":"Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and \u2013susceptible strains of Pseudomonas aeruginosa","volume":"18","author":"Livermore","year":"1984","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/47.3.247","article-title":"Of Pseudomonas porins, pumps and carbapenems","volume":"47","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.micro.56.012302.160310","article-title":"Function of pseudomonas porins in uptake and efflux","volume":"56","author":"Hancock","year":"2002","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2\u2013lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/AAC.46.11.3406-3411.2002","article-title":"Constitutive high expression of chromosomal \u03b2-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD","volume":"46","author":"Bagge","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1128\/AAC.42.12.3296","article-title":"Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression","volume":"42","author":"Langaee","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1128\/AAC.49.11.4733-4738.2005","article-title":"Molecular mechanisms of \u03b2-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains","volume":"49","author":"Juan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1128\/AAC.00172-08","article-title":"Benefit of having multiple ampD genes for acquiring \u03b2-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa","volume":"52","author":"Moya","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"e1000353","DOI":"10.1371\/journal.ppat.1000353","article-title":"Beta-lactam resistance response triggered by inactivation of nonessential penicillin-binding protein","volume":"5","author":"Moya","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.eimc.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkf069","article-title":"Identification of PSE and OXA \u03b2-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism","volume":"50","author":"Bert","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/AAC.42.8.1966","article-title":"Structure of CARB-4 and AER-1 carbenicillin hydrolizing \u03b2-lactamases","volume":"42","author":"Sanschagrin","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1099\/jmm.0.009142-0","article-title":"Pseudomonas aeruginosa\u2013a phenomenon of bacterial resistance","volume":"58","author":"Strateva","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.46.3.638-645.2002","article-title":"Molecular characterization of a novel class 1 integron containing blaGES-1 and fused product of aac(3)-Ib\/aac(6\u2032)-ib\u2032 gene cassettes in Pseudomonas aeruginosa","volume":"46","author":"Dubois","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/49.3.561","article-title":"A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum \u03b2-lactamase GES-2 in South Africa","volume":"49","author":"Poirel","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.01512-08","article-title":"Diversity, epidemiology, and genetics of class D beta-lactamases","volume":"54","author":"Poirel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1128\/AAC.45.6.1615-1620.2001","article-title":"Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa","volume":"45","author":"Aubert","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib22","doi-asserted-by":"crossref","unstructured":"Danel F, Hall LMC, Gur D, Livermore DM. OXA-15, an extended-spectrum variant of OXA-2 \u03b2-lactamase, isolated from Pseudomonas aeruginosa strain. Antimicrob Agents Chemother. 1998; 42: 3117\u201322","DOI":"10.1128\/AAC.42.12.3117"},{"key":"10.1016\/j.eimc.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/AAC.46.2.566-569.2002","article-title":"Integron-located oxa-32 gene cassette encoding extenden-spectrum variant of OXA-2 \u03b2-lactamase from Pseudomonas aeruginosa","volume":"46","author":"Poirel","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1128\/AAC.41.10.2188","article-title":"OXA-18, a class D clavulanic acid-inhibited extended-spectrum \u03b2-lactamase from Pseudomonas aeruginosa","volume":"41","author":"Philippon","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1128\/AAC.47.9.2859-2863.2003","article-title":"Molecular and biochemical characterization of OXA-45, an extended-spectrum clas 2d\u2019 \u03b2-lactamase in Pseudomonas aeruginosa","volume":"47","author":"Toleman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.patbio.2008.05.002","article-title":"First detection of the OXA-40 carbapenemase in Pseudomonas aeruginosa isolates, located on a plasmid also found in A. baumannii","volume":"57","author":"Sevillano","year":"2009","journal-title":"Pathol Biol"},{"key":"10.1016\/j.eimc.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapenemases in Gram-negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/AAC.40.2.349","article-title":"Multifocal outbreaks of metallo-\u03b2-lactamase producing Pseudomonas aeruginosa resistant to broad spectrum \u03b2-lactams, including carbapenems","volume":"40","author":"Senda","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1128\/AAC.43.7.1584","article-title":"Cloning and characterization of blaVim, a new integron-borne metallo-\u03b2-lactamase gene from a Pseudomonas aeruginosa clinical isolate","volume":"43","author":"Lauretti","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1128\/AAC.46.3.932-933.2002","article-title":"First isolation of a carbapenem-hydrolyzing \u03b2-lactamase in Pseudomonas aeruginosa in Spain","volume":"46","author":"Prats","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1469-0691.2007.01784.x","article-title":"Nosocomial spread of Pseudomonas aeruginosa producing the metallo-\u03b2-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications","volume":"13","author":"Pe\u00f1a","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.00810-07","article-title":"Carbapenem resistance in Pseudomonas aeruginosa from Spanish hospitals: Molecular epidemiology and mechanisms","volume":"51","author":"Guti\u00e9rrez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eimc.2009.01.013","article-title":"Caracterizaci\u00f3n molecular de aislados cl\u00ednicos de Pseudomonas aeruginosa productores de la metalobetalactamasa VIM-2 en Cantabria, Espa\u00f1a","volume":"28","author":"Rodriguez","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1128\/AAC.00465-08","article-title":"Characterization of the new metallo-\u03b2-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain","volume":"52","author":"Juan","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/dkf210","article-title":"Molecular characterization of SPM-1, a novel metallo-\u03b2-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme","volume":"50","author":"Toleman","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/AAC.48.12.4654-4661.2004","article-title":"Molecular characterization of a \u03b2-lactamase gene, blaGIM1, encoding a new subclass of metallo-\u03b2-lactamase","volume":"48","author":"Castanheira","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/AAC.00719-09","article-title":"First report of the metallo-\u03b2-lactamase SPM-1 in Europe","volume":"54","author":"El Salabi","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ja.2006.31","article-title":"Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa","volume":"59","author":"Sakyo","year":"2006","journal-title":"J Antibiot"},{"key":"10.1016\/j.eimc.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000239444","article-title":"Meropenem permeation through the outer membrane of Pseudomonas aeruginosa can involve pathways other than OprD porin channel","volume":"42","author":"P\u00e9rez","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1016\/j.eimc.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.eimc.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","article-title":"Clinical strains of Pseudomonas aeruginosa overproducing; exAB-OprM and MexXY efflux pumps simultaneously","volume":"48","author":"Llanes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1574-6968.1999.tb08709.x","article-title":"nal-B type mutations causing the overexpresion on the MexA-MexB-Oprm efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome","volume":"179","author":"Saito","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.eimc.2010.05.001_bib43_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/518605","article-title":"16S ribosomal RNA methylation: emerging resistance mechanisms against aminoglycosides","volume":"45","author":"Doi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2010.05.001_bib43_2","first-page":"785","article-title":"16S ribosomal RNA methylation: emerging resistance mechanisms against aminoglycosides","volume":"41","author":"Doi","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(03)14959-8","article-title":"Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa","volume":"362","author":"Yokoyama","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrates specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/315312","article-title":"Aminoglycoside resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment","volume":"181","author":"MacLeod","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/AAC.00704-06","article-title":"Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides","volume":"51","author":"El\u2019Garch","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid0702.010239","article-title":"Emerging mechanisms of fluoroquinolone resistance","volume":"7","author":"Hooper","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1128\/AAC.41.10.2289","article-title":"Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa","volume":"41","author":"Nakano","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/mdr.1998.4.257","article-title":"Mechanisms of quinolone sresistance in clinical strains of Pseudomonas aeruginosa","volume":"4","author":"Jalal","year":"1998","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.eimc.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","article-title":"Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracylines and fluoroquinolones as examples","volume":"37","author":"Nikaido","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","article-title":"High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation","volume":"46","author":"Nakajima","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.eimc.2010.05.001_bib53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nrmicro1789","article-title":"An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii","volume":"5","author":"Dijskhoorn","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1517\/14656566.9.4.587","article-title":"Therapeutic options for Acinetobacter baumannii infections","volume":"9","author":"Vila","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eimc.2010.05.001_bib55","first-page":"150","article-title":"Treatment of multiresistant Acinetobacter baumannii infections","volume":"10","author":"Pach\u00f3n","year":"2009","journal-title":"Curr Op Invest Drugs"},{"key":"10.1016\/j.eimc.2010.05.001_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/28.1.35","article-title":"Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance","volume":"28","author":"Sato","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/AAC.00732-07","article-title":"A resistant nodulation cel division pump effluxing multiple antibiotics in Acinetobacter baumannii","volume":"52","author":"Damier-Piolle","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib58","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1128\/AAC.00584-09","article-title":"CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii","volume":"53","author":"Roca","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib59","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jac\/dkg344","article-title":"Partial characterization of a transposon containing the tet(A) determinant in a clinicl isolate of Acinetobacter baumannii","volume":"52","author":"Ribera","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/AAC.37.1.138","article-title":"In Vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii","volume":"37","author":"Vila","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/AAC.22.2.323","article-title":"Transposon mediated multiple antibiotic resistance in Acinetobacter strains","volume":"22","author":"Devaud","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib62","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1128\/AAC.41.12.2757","article-title":"Cloning and nucleotide sequence an\u00e1lisis of a gene encoding an OXA-derived beta-lactamase in Acinetobacter baumannii","volume":"41","author":"Vila","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib63","first-page":"45","article-title":"Novel carbenicillin-hydrolyzing beta-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus","volume":"59","author":"Paul","year":"1989","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.eimc.2010.05.001_bib64","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1128\/AAC.01600-06","article-title":"Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina","volume":"51","author":"Poirel","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.44.2.428-432.2000","article-title":"Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii","volume":"44","author":"Bou","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/dkf092","article-title":"Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) in the MICs of different beta-lactam antibiotics","volume":"50","author":"Danes","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jac\/dkg407","article-title":"AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical isolates","volume":"52","author":"Corvec","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1574-6968.2007.00828.x","article-title":"Prevalence of ISAba1 in epidemiologically unrelated Acinetobacter baumannii clinical isolates","volume":"274","author":"Ruiz","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.eimc.2010.05.001_bib69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1574-6968.2006.00195.x","article-title":"The role of ISAba1 in expression of OXA carbapenemse genes in Acinetobacter baumannii","volume":"258","author":"Turton","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.eimc.2010.05.001_bib70","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.48.2.612-614.2004","article-title":"Genetic environment and transcription of ampC in Acinetobacter baumanii clinical isolate","volume":"48","author":"Segal","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib71","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/AAC.41.10.2265","article-title":"Widespread detection of PER-1-type extended spectrum beta-lactamases hmong nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multi-center study","volume":"41","author":"Vahabogl\u00fc","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib72","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/AAC.47.5.1749-1751.2003","article-title":"High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp in Korea","volume":"47","author":"Yong","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib73","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijantimicag.2006.08.032","article-title":"Inter-country transfer or PER-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii from Romania","volume":"29","author":"Naas","year":"2007","journal-title":"Inter J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2010.05.001_bib74","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkl178","article-title":"Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium","volume":"58","author":"Naas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib75","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jac\/dkl055","article-title":"Spread of blaCTX-M and blaPER-2 beta-lactamase genes in clinicl isolates from Bolivian hospitals","volume":"57","author":"Celenza","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/10766290260469516","article-title":"Characterization o fan integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii","volume":"8","author":"Navia","year":"2002","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.eimc.2010.05.001_bib77","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/JCM.42.9.3978-3984.2004","article-title":"Nosocomial transmisi\u00f3n of CTX-M-2 beta-lactamase producing Acinetobacter baumannii in a neurosurgery ward","volume":"42","author":"Nagano","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib78","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1128\/AAC.01139-06","article-title":"Spread in an italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase","volume":"51","author":"Endemiani","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib79","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jac\/dkm366","article-title":"Panresistant extended-spectrum beta-lactamase SHV-5-producing Acinetobacter baumannii from New York city","volume":"60","author":"Naas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib80","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/JCM.43.9.4862-4864.2005","article-title":"Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology","volume":"43","author":"Al Naiemi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib81","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/JCM.41.8.3542-3547.2003","article-title":"Outbreak of extended-spectrum beta-lactamase VEB-1 producing isolates of Acinetobacter baumannii in a French hospital","volume":"41","author":"Poirel","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib82","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1469-0691.2007.01825.x","article-title":"High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain","volume":"13","author":"Ruiz","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2010.05.001_bib83","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1128\/AAC.00856-09","article-title":"OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii","volume":"53","author":"Higgins","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib84","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo-beta-lactamases: the quiet before the storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2010.05.001_bib85","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/jac\/dkl509","article-title":"Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii","volume":"59","author":"Vila","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib86","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/JCM.37.3.758-761.1999","article-title":"Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain","volume":"37","author":"Vila","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib87","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1099\/jmm.0.45716-0","article-title":"Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones","volume":"53","author":"Nemec","year":"2004","journal-title":"J Med Microb"},{"key":"10.1016\/j.eimc.2010.05.001_bib88","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.45.12.3375-3380.2001","article-title":"Resistance-Nodulation-Cell Division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454","volume":"45","author":"Magnet","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib89","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/dkh427","article-title":"Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts Turing an outbreak of Acinetobacter baumannii","volume":"54","author":"Higgins","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib90","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/AAC.39.5.1201","article-title":"Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii","volume":"39","author":"Vila","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/39.6.757","article-title":"Quinolone resistance in the topoisomerase IV parC gene of Acinetobacter baumannii","volume":"39","author":"Vila","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib92","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/49.3.471","article-title":"Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates","volume":"49","author":"Vila","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib93","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/49.4.697","article-title":"Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates","volume":"49","author":"Ribera","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.11.1.57","article-title":"Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia","volume":"11","author":"Denton","year":"1998","journal-title":"Clin Microb Rev"},{"key":"10.1016\/j.eimc.2010.05.001_bib95","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/AAC.44.11.3079-3086.2000","article-title":"Cloning and characterization of SmeDEF, a novel efflux pump from Stenotrophomonas maltophilia","volume":"44","author":"Alonso","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib96","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2174\/138945008785747806","article-title":"Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors","volume":"9","author":"Vila","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.eimc.2010.05.001_bib97","doi-asserted-by":"crossref","DOI":"10.1089\/10766290260469499","article-title":"Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epdiemiological unrelated Stenotrophomonas maltophilia clinical isolates [en prensa]","author":"Ribera","year":"2002","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.eimc.2010.05.001_bib98","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.46.3.665-671.2002","article-title":"Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility","volume":"46","author":"Valdezate","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2180-8-148","article-title":"Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants","volume":"8","author":"S\u00e1nchez","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.eimc.2010.05.001_bib100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.00496-09","article-title":"SmQnr contribuyes to intr\u00ednsic resistance to quinolones in Stenotrophomonas maltophilia","volume":"54","author":"S\u00e1nchez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2010.05.001_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0732-8893(01)00335-2","article-title":"In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and abscence of reserpine","volume":"42","author":"Ribera","year":"2002","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2010.05.001_bib102","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.45.5.1581-1584.2001","article-title":"Antimicrobi al susceptibilities of unique Stenotrophomonas maltophilia clinical strains","volume":"45","author":"Valdezate","year":"2001","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X10002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X10002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T09:37:16Z","timestamp":1591436236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X10002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0213005X10002181"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2010.05.001","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}